Trajenta Tablets (Linagliptin)

Adult dose

Take 5 mg once daily. It can be administered regardless of meals.

This medication should not be used by individuals who are allergic to the active ingredient or other components of this medication. Additionally, it should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. When using this medication, caution is required when taking other medications that can induce hypoglycemia. The risk of hypoglycemia may increase when used in combination with insulin or sulfonylureas, as they stimulate insulin secretion, which may necessitate dosage adjustment. This medication should be used cautiously in patients with heart failure. Acute pancreatitis may occur during treatment, so if severe abdominal pain occurs, discontinue use immediately and consult a physician. Skin conditions such as bullous pemphigoid may develop during treatment; therefore, if blisters or skin rash occur, notify a physician immediately. Hypoglycemic symptoms may occur during treatment, especially when taken with sulfonylureas or insulin, so pay attention to signs of hypoglycemia. Use of this medication during pregnancy or lactation is not recommended, and consultation with a doctor is required prior to use. It is advisable to avoid use in children under 10 years old, as safety and efficacy have not been established. Elderly patients can use it without special dosage adjustments, but caution may be warranted depending on health status. Patients with impaired renal or liver function may use it without dosage adjustments, but regular medical supervision is necessary. In case of overdose, there is no specific antidote, so it is important to receive appropriate treatment based on symptoms. This medication should be stored out of reach of children and should not be transferred to another container.

Serious side effects

Hives, angioedema, pancreatitis, bullous pemphigoid, severe swelling (edema), chest tightness, difficulty breathing, severe allergic reaction, severe skin adverse reaction, acute pancreatitis, acute myocardial infarction, congestive heart failure, cardiac arrest, acute kidney injury, end-stage kidney disease, acute cholangitis, acute cholecystitis, cholangitis, severe neurological symptoms (headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis), shortness of breath,

Mild side effects

• Hypoglycemia
• hypertriglyceridemia
• hyperlipidemia
• cough
• constipation
• oral ulcers
• rash
• musculoskeletal disorders
• weight gain
• increased lipase

This medication should be stored in a tightly closed container due to its sensitivity to air and moisture. It is recommended to maintain room temperature between 1 to 30 degrees Celsius. This will help preserve the efficacy and safety of the medication for a longer period.

Appearance

Round film-coated tablets that are bright red, convex on both sides, with sharp edges. One side is marked with the Boehringer Ingelheim logo, and the other side is engraved with 'D5'.

Package unit

30 tablets (10 tablets/PTP x 3)